RxDoctor Payments Data

Michael Wall, PA

Physician Assistant · Clinton, NCNPI 1407244007

Payments from drug & device makers

$405in general payments, 2019–2025

Across 22 payments — averaging $18.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$92
  • Exact Sciences$80
  • AstraZeneca$46
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$39
  • Lilly USA, LLC$32
  • Lundbeck LLC$30
  • plus $86 from 4 others

What the payments were for

  • Food & beverage$405100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$405 in reported general payments places this provider in the 55th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$163,845
Medicare patients
381
Services billed
3,363

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide111$145,418
JardianceEmpagliflozin97$144,255
Trelegy ElliptaFluticasone/Umeclidin/Vilanter89$102,655
RinvoqUpadacitinib14$100,206
EliquisApixaban71$76,984
TrulicityDulaglutide38$64,664
OzempicSemaglutide36$60,956
VraylarCariprazine Hcl32$51,750
JanuviaSitagliptin Phosphate40$40,800
FarxigaDapagliflozin Propanediol28$32,707
RybelsusSemaglutide18$30,942
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr32$27,936
Breztri AerosphereBudesonide/Glycopyr/Formoterol25$25,818
XareltoRivaroxaban20$25,279
Stiolto RespimatTiotropium Br/Olodaterol Hcl15$21,832

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$32$210,082149 claims
AbbVieRinvoq, Vraylar, Synthroid$92$154,14470 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$46$65,18069 claims
MerckJanuvia, Belsomra$27$51,78360 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Clinton

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →